12/27/2012
Charles River Laboratories International, Inc. announced the signing of an agreement to acquire 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.
12/12/2012
An innovative approach to the quality control of laboratory rodents using high-throughput PCR panels means that laboratories can now determine more definitively not only whether a population is infected, but which individuals carry a given pathogen.
12/04/2012
Recent technological advances have dramatically broadened the scope of safety pharmacology studies as originally envisioned in the International Conference on Harmonization (ICH) S7A and S7B guidances. Recent revisions to the ICH S6(R1) guidance state that safety pharmacology “may be investigated in separate studies or incorporated in the design of toxicity studies” for biotechnology-derived products.
11/15/2012
Most contract research organizations (CROs) offer a wide variety of services ranging from preclinical studies and consultancy/advice to full clinical trials and regulatory support.
10/31/2012
Patrick Sweeney, Managing Director, Discovery Research Services - Finland, shares nine tips to ensure imaging in a preclinical space generates more translatable data across all disease states...
10/29/2012
Charles River Laboratories enters in strategic partnership with AstraZeneca for safety assessment, drug metabolism and pharmacokinetics testing services.
10/17/2012
James C. Foster, Chairman, President and Chief Executive Officer of Charles River, said, “We are extremely pleased that AstraZeneca selected Charles River as its strategic in vivo biology partner.
10/09/2012
In August 2012, Charles River Laboratories (CRL) acquired Accugenix for $17 million. The move is intended to boost CRL’s Endotoxin and Microbial Detection (EMD) portfolio of products and services.
10/08/2012
Charles River's aquisition of Accugenix is the first step to the broader strategy of becoming the premier provider of rapid microbial and endotoxin detection products and services to the biopharmaceutical industry.
09/19/2012
Shipping animals between institutions can increase the risk for contamination, especially when an institution’s health status is unknown.